TYMLOS for Postmenopausal Women with Osteoporosis [transcript] [audio]
Key Takeaways
- Why It Matters: This discussion provides healthcare professionals with actionable insights relevant to clinical practice and patient care.
- Key Point: Listen to the full episode for detailed discussion and professional insights on this important healthcare topic.
- Key Point: Listen to the full episode for detailed discussion and professional insights on this important healthcare topic.
- Key Point: Listen to the full episode for detailed discussion and professional insights on this important healthcare topic.
- Key Point: Listen to the full episode for detailed discussion and professional insights on this important healthcare topic.
Segment Overview: Dr. Barry Jacobson, a board-certified Crozer-Keystone gynecologist, discusses the crisis in the treatment of osteoporosis, gaps in treatment, and the new FDA approved treatment – Radius Health‘s TYMLOS ™ (abaloparatide) for postmenopausal women with osteoporosis at high risk for fracture. For more information and full ISI,
Guest: Dr. Barry Jacobson
Presenter: Neal Howard
Guest Bio: Barry Jacobson, M.D., a board-certified Crozer-Keystone gynecologist, the Osteoporosis Center of Delaware County is dedicated to the detection and comprehensive treatment of osteoporosis. Jacobson has been treating patients with osteoporosis and sharing his knowledge on this topic with the national medical community since 1998. For more information and full ISI, visit www.Tymlos.com
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
